How Is Multiple Sclerosis Diagnosed? An MS Expert Explains

Multiple sclerosis (MS) is an inflammatory disease in which the immune system attacks the central nervous system, damaging the myelin, the protective covering around certain nerves.

Over the last 20 years, multiple sclerosis has become a highly manageable disease. While there is no cure, new therapies can lessen the effects of MS and improve your quality of life, according to Mount Sinai’s Corinne Goldsmith Dickinson Center for Multiple Sclerosis.

In this Q&A, Ilana Katz Sand, MD, the Center’s Associate Director and Professor of Neurology at the Icahn School of Medicine at Mount Sinai, explains why it can be difficult to diagnose MS and what you can do if you are misdiagnosed.

How is multiple sclerosis diagnosed?

Unfortunately, there is no single diagnostic test for MS. Rather, an MS diagnosis is made by considering all available data and appropriately applying the diagnostic criteria. Clinicians review a patient’s medical history and symptoms, perform a neurological examination, and use magnetic resonance imaging, or MRI, to make a non-invasive scan of the brain and spinal cord. They will sometimes recommend a lumbar puncture (spinal tap) for additional information.

Other testing, such as examining the optic nerves, and blood tests to appropriately rule out other conditions, may also be performed. Any potential “red flags” to an MS diagnosis must be considered and the diagnostic criteria must then be carefully applied.

What are some overlapping symptoms between MS and other conditions?

What can sometimes make the diagnostic process difficult is that symptoms of MS can overlap with those of other conditions. For example, optic neuritis, an inflammation of the optic nerve that can cause pain and vision loss, is a common presenting symptom of MS. It is also a common presenting symptom of other inflammatory conditions such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disorder.

These conditions are also associated with lesions in the brain and spinal cord like MS. Other symptoms that are common in MS, such as fatigue and cognitive fogginess, are common in many other illnesses and are not specific to MS. Clinicians need to use clues from the way the symptoms present, the pattern of lesions on the MRI scan, blood and spinal fluid testing, and sometimes additional diagnostic tests to help differentiate MS from other conditions when it is not initially clear.

How common is it to misdiagnose MS?

Misdiagnosis of MS is not that uncommon. Research suggests that among referrals to medical centers that specialize in multiple sclerosis and offer advanced care, the rate of MS misdiagnosis may be as high as 20 percent. This is consistent with my personal experience over the years.

In my experience, misdiagnosis most commonly occurs when the clinician has not considered a diagnostic “red flag” carefully enough or has inappropriately applied the MS diagnostic criteria when a patient’s history, exam, or MRI findings are not typical for MS.

A change in clinical impression can also occur when new technology becomes available that causes the clinician to see things a different way. However, the numbers we see in research studies do not necessarily mean that one in five people who currently have an MS diagnosis have been misdiagnosed. Patients who are referred to advanced care centers tend to be more challenging cases, so this likely introduces some bias into this figure. The rate of misdiagnosis in the overall population is probably lower.

What should someone do if they have been misdiagnosed with MS but are still experiencing symptoms?

For someone who previously received an MS diagnosis but has since been told the diagnosis was not correct, the most important action is to understand why the clinician has changed their impression.

The next steps will be different depending on whether a new lab test result became available, clinical symptoms have changed (for example, there has been a lack of expected response to treatment), or the MRI scan has evolved in a way that was different than anticipated.

The clinical reasoning should drive next steps for further evaluation of the patient’s ongoing symptoms. The other action item I recommend is focusing on symptom management, taking a holistic view of care that incorporates optimizing things like nutrition, exercise and physical activity, and mental health. Attention to these parts of care can make a really big difference in the way a person feels regardless of their diagnosis.

The Value of Nursing Research: Nursing Research Day 2026

 

A photo of Dana M. Womack, Assistant Professor of Medical Informatics and Clinical Epidemiology, School of Medicine, and Assistant Professor, School of Nursing, Oregon Health & Science University, keynote speaker at Nursing Research Day 2024.

Dana M. Womack, Assistant Professor of Medical Informatics and Clinical Epidemiology, School of Medicine, and Assistant Professor, School of Nursing, Oregon Health & Science University, keynote speaker at Nursing Research Day 2024.

Nurses do so much more than provide care to patients.

Behind the scenes throughout the Health System, Mount Sinai nurses lead initiatives to improve patient outcomes, advance practice, and promote the efficient delivery of care. Much of this work will be on display during the Health System’s annual Nursing Research Day, which will take place on Friday, November 6, from 8:45 am to 4:30 pm at The Mount Sinai Hospital’s Stern Auditorium.

The theme for this year’s event, “The Value of Nursing Research,” highlights the value of research and innovation projects conducted by nurses in clinical settings. All members of the Mount Sinai community as well as other New York-region health care institutions are welcome to attend.

“Hearing how other nurses identify a problem, evaluate evidence, and measure change can help attendees consider improvements in their own practice,” says Taleisia Babatunde, MS, RN, a recent graduate from the Mount Sinai Phillips School of Nursing. “Their everyday observations and questions can be the starting point for meaningful research or quality improvement.”

Ms. Babatunde will present her quality improvement (QI) project designed to promote early moving after cesarean section by improving nursing students’ and postpartum nurses’ understanding of its benefits, barriers, and appropriate timing.

Hosted annually by the Center for Nursing Research and Innovation (CNRI) at Mount Sinai, Nursing Research Day showcases Mount Sinai nurses who are advancing the profession and improving patient care through their own research, quality improvement projects, and evidence-based practice (EBP) projects.

The variety and depth of the work being done throughout Mount Sinai is impressive.

A photo of Nursing Research Day 2024

Kimberly Souffront, PhD, RN, FNP-BC, FAAN, Associate Director, Center for Nursing Research and Innovation, speaking with Translational Research and Implementation Science for Nurses (TRAIN) Program cohort members Arezo Aziz, DNP, MSN, MS, RN, FNP-BC, Sarla Santos, MSN, RN, NPD-BC, CCRN, Kafayat Abba, MSN, RN, CDP, CCRN, CMC, NE-BC, Victoria Puplampu, BSN, RN (seated from left to right), and Jah’ Vonie Cooke, BSN, RN, LP, CNA (on screen) at Nursing Research Day 2024.

“I truly believe that nursing science starts at the bedside,” says Keiko Iwama, PhD, MSN, RN, CCRN, Staff Nurse, 6 East CCU/CSICU, Mount Sinai Morningside. On behalf of the Mount Sinai Morningside EBP/Nursing Research Council, she will present findings from a bedside nurse-led QI project exploring non-critical care nurses’ perceived barriers to participating in codes and rapid responses. “Bedside nurses should feel empowered to improve nursing practice while improving patient outcomes through research,” she says.

Xiomara Dorrejo, MS, AGPCPN-BC, nurse practitioner, The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, will present a QI project that focused on improving bowel preparation adequacy among general GI patients undergoing a colonoscopy. “Nursing Research Day offers an opportunity for nurses from different backgrounds and patient populations to connect,” says Ms. Dorrejo. “It sparks creative thinking and shows that nurses at every level can drive change for their patients.”

“No one spends more time with patients than nurses,” adds Leah Estrada, PhD, MA, RN, Assistant Professor, Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai and Nurse Scientist at the CNRI. “It makes sense that we need to be directly involved in research that improves health care.”

A photo of Nursing Research Day 2024

Alyssa Ramkissoon, RN, BSN, presents the findings of her Mount Sinai Phillips School of Nursing Evidence-Based Practice Fellowship project, “Enhancing Nursing Communication in Palliative Care Through the COMFORT Model’s Connect Module,” at Nursing Research Day 2024.

Dr. Estrada will present her research exploring the palliative care needs of Latino family caregivers of persons living with dementia, funded by the Robert Wood Johnson Foundation’s Harold Amos Medical Faculty Development Program.

“This study helped identify communication gaps between primary care providers, families and patients,” she says. Dr. Estrada will be working to improve these gaps through a five-year grant recently awarded by the National Institute on Aging, National Institutes of Health.

Jonathan DePierro, PhD, Associate Director of the Center for Stress, Resilience and Personal Growth at the Icahn School of Medicine at Mount Sinai, will present research supported by a grant from the Health Resources and Services Administration. Dr. DePierro and a team of clinicians and researchers evaluated mental health and wellbeing among staff, including nurses. “We found that perceived support from direct leadership was associated with both better mental health outcomes and a lower intent to leave the institution,” says Dr. DePierro. The team will present how they have used their findings to inform multilevel support programing available to nurses across Mount Sinai.

“Any Mount Sinai nurse who has an interest in improving care delivery or the care environment will gain a lot at Nursing Research Day,” says Bevin Cohen, PhD, MS, MPH, RN, Director of the CNRI. “Most nurses are doing systematic inquiry without even realizing it. We need everyone to recognize and learn from their work. Nursing Research Day is one place where nurses can connect with colleagues and learn about the resources available to support and disseminate nurse-led projects.”

Nursing Research Day 2026 Features Keynote Speaker Olga Yakusheva, PHD, MSPE, FAAN

 

In addition to research, EBP, and QI project presentations by Mount Sinai nurses, Nursing Research Day 2026: The Value of Nursing Research will feature a keynote by Olga Yakusheva, PHD, MSPE, FAAN, Professor of Nursing, Johns Hopkins School of Nursing. Dr. Yakusheva is an internationally renowned economist whose research is shaping national policy around the economic value of nursing and its contribution to patient, societal, and organizational outcomes. Her expertise will frame an emerging national conversation about the return on investment in nursing innovation projects in the clinical setting.Please join this important national conversation about the value of nursing research, hear from nurses across the Health System as they present their transformative findings, and learn how to begin a project of your own. Click here for more information and to register.

How Mount Sinai’s MHA Program Transformed This New Yorker’s Approach to Health Care

A photo of Toure Jacobs, MHA

Toure Jacobs, MHA

Toure Jacobs, a native of the Bronx, New York, completed his Master of Health Administration (MHA) program at the Icahn School of Medicine at Mount Sinai in June 2026. That training would ultimately enhance his role as a Unit Secretary at Mount Sinai Morningside, where he manages daily administrative operations, ensuring seamless communication between departments.

Mr. Jacobs started his undergraduate education studying computer science at the University of Buffalo. He soon found that he wasn’t passionate about this subject; he didn’t see his existing skills translating into the work he wanted to do. He had worked in education and child development and enjoyed working with people. So he switched his major to business and completed his Bachelor of Business Administration at Baruch College in New York City.

Mr. Jacobs’ father worked at Mount Sinai Morningside and encouraged him to apply for jobs there. He received an offer from the Medical-Surgical Unit as a Unit Secretary. He worked in that department for two years before participating in an internship on the Strategic Planning team at Mount Sinai. The objective was to improve Operating Room operations, seeking to cut down on operating times. Mr. Jacobs enjoyed seeing the process behind the scenes and understanding how operations concepts turned into action that helped patients. His experience in this role and his internship preceptor inspired him to apply to the MHA program at the Icahn School of Medicine.

Several courses made a significant impact on Mr. Jacobs during his time as a graduate student. His favorite course was Strategic Planning, taught by Sofia Pendley, PhD, Professor of Environmental Medicine, and Graduate Education, where he learned how each team contributes to health care operations. He also learned about how all the planning pieces come together to improve systems in both complex health environments and smaller organizations, such as startup companies. While in this course, he created a marketing campaign for PrEP (pre‑exposure prophylaxis), which is a medication taken before exposure to HIV to prevent infection. Mr. Jacobs felt that he was able to make a real impact through this campaign. Dr. Pendley played a major role in shaping his thinking around health care strategy.

Professionalism and Ethics, taught by Matt Baney, Associate Director of the Master’s in Healthcare Administration Program, is another course that he found very useful. This course taught him about different leadership styles and how to handle decision making in a leadership role. It also inspired him to reflect on his own professional conduct in his job before joining the MHA program.

“I want to help build health care systems that people can trust, access, and believe are working for them. In communities like mine, changes in policy and regulation can deepen fear, uncertainty, and barriers that already exist.” — Toure Jacobs, MHA.

Mr. Jacobs credits mentors like Victoria Ellsworth, MHA, Vice President, Hospital Operations, The Mount Sinai Hospital, for his success in the MHA program. Ms. Ellsworth encouraged him to consider several career placement options and to develop long-term goals. He also mentioned Brian Nickerson, PhD, a former senior associate dean, who came to know Mr. Jacobs on a personal level and provided helpful career guidance.

The welcoming environment at Mount Sinai has proven beneficial for Mr. Jacobs. Throughout the program, he became an active part of the MHA community while continuing his work at Mount Sinai Morningside. He built close relationships with classmates, mentors, and colleagues, and his experience brought a frontline perspective to a cohort preparing for leadership across health care.

The lessons from the MHA program manifested in several ways for Mr. Jacobs in his role as a Unit Secretary. He initially worked evenings, but with the MHA program classes taking place at night, he moved from the Medical-Surgery Unit to the Geriatric Psychiatry Unit. Mr. Jacobs discovered a big difference between serving a psychiatric unit as opposed to his previous role in a clinical unit. He found that a behavioral unit had unique challenges and barriers that he didn’t experience in his previous role.

For example, if a clinical patient had specific dietary needs, he could simply communicate this to nursing staff and make the appropriate changes to the food they received. In a psychiatric unit, Mr. Jacobs had to learn new rules and adjust how he accommodated patients accordingly.

Challenges would arise when the unit received admissions that fell outside of their typical patient demographic, such as younger adult patients. He worked with the team to identify activities and accommodations that better reflected the needs and interests of those patients, such as incorporating music through the overhead speaker system and providing personal handheld radios for patients who preferred their own listening space.

“I want to help build health care systems that people can trust, access, and believe are working for them. In communities like mine, changes in policy and regulation can deepen fear, uncertainty, and barriers that already exist,” he says.

Mr. Jacobs values the perspective his front-line experience at Mount Sinai Morningside has given him and has increasingly looked for opportunities to apply his MHA training to operational challenges. He helped create a staffing matrix that alternates responsibilities efficiently between the team members. This gives team members opportunities to rotate through different responsibilities and develop a broader understanding of how the unit operates.

Mr. Jacobs would like to continue leading and implementing organizational projects such as this. His long-term goal is to grow into a health care leadership role where he can combine operations, strategic planning, and community engagement to improve how health systems serve their patients.

“The next generation of health care leaders has to do more than respond to those challenges after the fact,” he says. “We have to understand the communities being affected, earn their trust, and build systems that do not leave them behind. That is the kind of leader I am working to become: someone who can help turn uncertainty into trust, barriers into access, and change into progress.”

Rethinking Postpartum Care: A More Connected Path for New Mothers

For generations, the six-week postpartum visit has served as a kind of finish line: an appointment marking the end of pregnancy-related care and the beginning of “normal” life again. But for many women, six weeks is hardly the end of recovery.

Physical healing can continue for months. Sleep deprivation and hormonal changes can affect emotional well-being. Pelvic floor symptoms, changes in sexual health, nutrition concerns, and questions about returning to exercise may emerge gradually. For women who experienced complications during pregnancy or delivery, the postpartum period can also be an important time to consider longer-term health.

In recent years, that understanding is beginning to reshape the way clinicians think about postpartum care. The American College of Obstetricians and Gynecologists describes postpartum care as an ongoing process rather than a single encounter, with care tailored to a woman’s individual physical, social, and psychological needs.

It is within this changing landscape that the Carolyn Rowan Center for Women’s Health and Wellness at Mount Sinai is developing MyPath Moms, a 16-week guided postpartum care journey for women seeking a more coordinated approach to recovery. MyPath Moms is designed to complement, not replace, routine postpartum care with a patient’s obstetrician, including the standard postpartum visit.

“Postpartum care shouldn’t be about checking a box and telling a woman she’s cleared to move on,” says Francesco Callipari, MD, an obstetrician/gynecologist and Medical Director of the Rowan Women’s Health Center. “There are many aspects of recovery that deserve attention, and every woman’s experience is different. Our goal is to create space for those conversations and make sure that new moms get the care and support available to them.”

MyPath Moms brings several areas of postpartum health into a planned health journey, including physical recovery, emotional health, nutrition, sexual wellness, and pelvic floor care.

“Rather than requiring a woman to navigate each concern independently, the members of her care team communicate with one another and work from a shared understanding of her needs,” says Dr. Callipari.

Much of the experience is designed to take place virtually, an approach that acknowledges a practical reality of new parenthood: Getting to appointments can be difficult when there is a newborn at home. A smaller number of visits will take place in person at the Rowan Women’s Health Center on Manhattan’s Upper East Side.

The MyPath Moms care journey is intended for women who are eight weeks to one year postpartum following a delivery at or after 24 weeks of pregnancy. For women whose pregnancies included conditions such as hypertension, preeclampsia, gestational diabetes, postpartum depression, or a more complicated delivery, MyPath Moms+ adds specialty care when clinically appropriate. Those services may include cardiology, endocrinology, psychiatry, or maternal-fetal medicine.

“Sometimes women think that once the baby is born, the focus naturally shifts away from them,” says Melanie Lucks, MMS, PA-C, Senior Physician Associate, Rowan Women’s Health Center.  “But this is a time when women may have symptoms they weren’t expecting or are having difficulty managing. We want them to feel that those concerns are worth bringing forward and that they do not have to figure everything out on their own.”

That philosophy reflects a broader shift in women’s health by recognizing that a healthy postpartum experience is not simply about whether a woman has physically healed from delivery. It is also about how she is feeling, functioning, adapting, and planning for her future health.

What Your Pregnancy and Postpartum Can Reveal About Your Long-Term Health

For many women, pregnancy is a season of appointments, ultrasounds, and anticipation. At the end of it, there is a new baby. But doctors and researchers are increasingly looking at pregnancy through another lens: as an early window into a woman’s future health.

Pregnancy asks a lot of nearly every system in your body. Your heart works harder. Your blood vessels adapt. Your blood sugar and metabolism shift. Your blood volume increases.  How the body responds to these demands can sometimes provide early clues about a woman’s risk for health conditions years or even decades later.

“Pregnancy is almost like a natural stress test,” says Joanne Stone, MD, MS, a maternal fetal medicine specialist and Chair of the Department of Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. “It puts demands on the cardiovascular and metabolic systems that can reveal risks that might otherwise go unnoticed.”

That makes your pregnancy history an important chapter in your lifelong health story. It is also why Mount Sinai is introducing MyPath Moms, a comprehensive, personalized care experience.

When pregnancy sends a signal

Conditions such as preeclampsia (high blood pressure that occurs generally later in pregnancy), gestational hypertension, and gestational diabetes are often viewed as complications that end when pregnancy ends. But research increasingly suggests they can also be markers of future cardiovascular and metabolic health.

Women who experience preeclampsia, for example, have a higher risk of developing high blood pressure and cardiovascular disease later in life. Gestational diabetes (diabetes that develops during pregnancy and then resolves after birth) is associated with an increased risk of type 2 diabetes and other metabolic problems. Preterm birth and having a baby who is small for gestational age may also signal increased cardiovascular risk for the mother.

“That doesn’t mean that having one of these complications means you are destined to develop heart disease or diabetes,” says Francesco Callipari, MD, Medical Director of the Carolyn Rowan Center for Women’s Health and Wellness and Assistant Clinical Professor and Vice Chair of Operations, Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine. “It means we have information we can use. And information gives us an opportunity to be proactive.”

Your pregnancy and postpartum history belongs in your medical history

Once a baby arrives, however, a mother’s health can quickly take a back seat. The routine postpartum visit is an important part of care, but recovery does not end at six weeks. Nor does the health information revealed by pregnancy and the postpartum period stop being relevant once that visit is over.

Pregnancy and postpartum experiences can provide clues about future health across several domains. High blood pressure, preeclampsia, gestational diabetes, preterm birth, and fetal growth problems can signal increased cardiovascular or metabolic risk. Depression, anxiety, or other significant mood symptoms during pregnancy or postpartum can also be important markers of a woman’s future mental health, including during later periods of hormonal change. “Postpartum care shouldn’t be viewed as a finish line,” says Melanie Lucks, MMS, PA-C, Senior Physician Associate at the Rowan Women’s Health Center. “It’s really the beginning of the next phase of a woman’s health.”

Make sure your health care team knows If you experienced any of the following during your pregnancy:

  • high blood pressure
  • preeclampsia
  • gestational diabetes
  • preterm birth
  • complicated delivery
  • significant emotional challenges during or after pregnancy

Turning a health challenge into an opportunity

The good news? A pregnancy complication is not a forecast. It is an opportunity to pay attention earlier.

That might mean monitoring blood pressure, checking cholesterol or blood sugar, addressing nutrition and physical activity, treating iron deficiency, supporting mental health, and connecting with a specialist when appropriate. Sometimes the most powerful intervention is simply recognizing that a woman deserves continued care after the baby is born.

This is the thinking behind MyPath Moms+, an enhanced 16-week postpartum care experience from the Rowan Women’s Health Center for women whose pregnancies revealed added complexity.

Designed for women eight weeks to one year postpartum following a delivery at or after 24 weeks of pregnancy, MyPath Moms+ combines whole-person postpartum care—including physical recovery, emotional health, nutrition, sexual wellness, and pelvic floor care—with additional specialist visits when clinically appropriate. Depending on your individual needs, that may include seeing specialists in cardiology, endocrinology, psychiatry, or maternal-fetal medicine.

Instead of navigating disconnected appointments on your own, a coordinated team shares information and helps guide your care.

Your pregnancy is not simply a chapter that has closed. It may be the earliest glimpse you will ever have of the health you want to protect for decades to come.

Ready to look beyond the six-week checkup?

MyPath Moms and MyPath Moms+ may be right for you. Enrollment is based on clinical fit. The 16-week guided experience includes an $800 program fee for supplemental services and care coordination not covered by insurance; medical visits and testing are billed to insurance according to individual coverage. Full financial details are reviewed before enrollment.

Find out more about MyPath Moms or call the Rowan Women’s Health Center to make an appointment: 212-731-3609.

Training the Next Generation of Psychiatric Physician-Scientists at Mount Sinai

A photo of Deepak Kaji, MD, PhD

Deepak Kaji, MD, PhD

Each year, medical schools confer MD-PhD degrees to those willing to devote years to doctoral research alongside their clinical training. However, the residencies that follow are typically structured so that many aspiring physician-scientists end up becoming one rather than both.

“Residencies rarely make sufficient room for physicians to also train as scientists, and we’re losing a lot of physician-scientists because of it,” says Deepak Kaji, MD, PhD, an Assistant Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai.

Because the PhD is sandwiched between years of medical school, MD-PhDs arrive at their residency program after two years away from the bench. Afterward, physicians must either look for postdoctoral positions to reorient themselves to a lab or bid farewell to that part of their training.

Dr. Kaji found a rare opportunity in the National Institutes of Health-funded R25 Physician-Scientist Training Program within the Psychiatry Residency at The Mount Sinai Hospital.

“Choosing Mount Sinai allowed me to begin building my research career on day one instead of starting a decade later,” he says.

Recruiting the Right People

As an undergraduate, Dr. Kaji studied how to direct pluripotent stem cells toward becoming heart tissue, an entry point into what he describes as the field’s central marvel.

“Every human being begins as a ball of cells with essentially infinite potential,” he explains. “Somehow, nature guides those cells toward becoming hair, teeth, pancreas, liver, or the heart.”

His affinity for stem cell research arrived as scientists were learning to reproduce that process in a dish. Gordon Keller, PhD, then at Mount Sinai, was coaxing stem cells into heart tissue, while others were making pancreas and brain tissue. For Dr. Kaji, watching those lineages being built for the first time was both exciting and an invitation.

“The idea of making something new felt like a crowning achievement,” he says.

When Dr. Kaji first showed interest in the MD-PhD program at Mount Sinai, program leadership emphasized the physician-scientist track residencies as a selling point. “They told me that being a scientist and a physician would dovetail, that each would make me better at the other,” he says.

It was encouraging that they were describing their residency program to someone who had not yet started medical school. This approach suggested they were thinking about the entire arc of a career, not just the next four years.

Applying Stem Cell Biology to Psychiatry Research

In the MD-PhD program, Dr. Kaji applied his stem cell biology background to musculoskeletal biology. His doctoral work focused on generating a protocol to create tendons and fibrocartilage from stem cells.

Returning to the clinical portion of medical school, he found himself drawn to psychiatry and investigating the mysteries of the brain and behavior. The question was then how to deploy his scientific training.

“Once I knew what I wanted to do, I started thinking about ways to apply my techniques to generate organoids as models of specific brain regions,” says Dr. Kaji. An organoid is a cluster of cells grown in a lab to mimic some of the structure and functions of a real organ.

“Choosing Mount Sinai allowed me to begin building my research career on day one instead of starting a decade later.” — Deepak Kaji, MD, PhD

Dr. Kaji began investigating schizophrenia based on his conviction that the disease starts far earlier than its diagnosis suggests.

“In twin studies, the twin who eventually develops the disorder is typically late to walk, speak, and potty train,” explains Dr. Kaji. “That gradual developmental divergence signals a slow degradation of the cognitive repertoire that happens for decades before the disease outwardly manifests.”

This is precisely the developmental window an organoid occupies by recapitulating the earliest phases of brain development. His proposal to use organoids as a model system to study schizophrenia earned him the 2024–2025 Lipschultz Research Scholar Award from the Friedman Brain Institute.

Neuropsychiatric disease is difficult to study—it is hard to explain why something in the brain breaks when no one fully understands how the brain works. Although an organoid does not answer every question, it offers insights that other models cannot.

“If you want to know how the disease disrupts high-order circuitry, this isn’t your system,” Dr. Kaji says. “If you want to know what happens as those circuits are being assembled, as cells differentiate and the brain organizes in the first trimester, it’s a great one.”

Creating New Tools for Hard Questions

One revelation from his work is the role of cell-autonomous effects, meaning that a cell’s identity may drive its vulnerability to disease. Dr. Kaji explains that radial glial cells, an early brain progenitor, appear heavily disrupted in organoids generated using stem cells from patients with schizophrenia.

“We’re seeing powerful disruptions in this one cell type at a developmental stage before any type of circuitry has formed,” he says. This suggests that vulnerability is a consequence of the molecular programming responsible for a cell’s final identity.

“Organoids allow me to build the cells, watch them come into existence, and ask how those programs confer vulnerability or resilience,” explains Dr. Kaji.

But that question can only be asked about cell types that science knows how to build. Protocols do not yet exist for every lineage, the developmental route a stem cell takes to become one specific cell type. Because building a brain region means learning how to make the cell types that define it, that gap leaves some regions off-limits to organoid research.

The hippocampus region of the brain is Dr. Kaji’s current focus. “I can’t think of a single neuropsychiatric or neurodegenerative disease without hippocampal involvement,” he says. “I’m working on creating hippocampal organoids because a better tool improves every disease model that follows.”

The benefit would also extend beyond individual diseases. Dr. Kaji notes that in Alzheimer’s disease, some regions are affected early, some late, and some almost never.

“This suggests that cells in each region show an intrinsic vulnerability or resistance to the disease,” he explains. “If we could identify what makes cells resilient, the next question is whether that resilience could be extended to vulnerable cells.”

A Long-Term Investment in Physician-Scientists

After entering the MD-PhD program, Dr. Kaji watched those ahead of him in the physician-scientist track and saw a pattern. They found mentors suited to their interests, began building research programs during residency, and left with faculty positions and career development awards that help confer scientific independence.

“It’s not uncommon for people to receive a K Award in their 40s,” he says, describing the National Institutes of Health Career Development Award grants designed to help early-career researchers become independent scientists. “I was watching people here get them in their mid-30s because the residency program followed through on its promise to make time for research.”

That track record has produced a faculty population that is substantially homegrown. Approximately 50 percent of those who complete the Psychiatry Physician-Scientist Residency Program stay at Mount Sinai, which Dr. Kaji sees as a sign of mutual respect.

His own transition from resident to faculty member was smoother than most, the product of a decade of relationships built as a student and resident. He just received his K08 career development award and now runs a lab two floors above where he completed his doctoral work, in a building where his former instructors are now his colleagues.

“They never stop investing in us,” he says. “For those who stay, there is a real commitment to helping us finish what we set out to build.”